Clinical Trial: Efficacy and Safety of CD20 Monoclonal Antibody Combined with Tacrolimus versus Standard of Care in Active Lupus Nephritis: A Randomized, Open-label, Exploratory Study (China)

China, Aug. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of CD20 Monoclonal Antibody Combined with Tacrolimus versus Standard of Care in Active Lupus Nephritis: A Randomized, Open-label, Exploratory Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130027

Registration Time: 2026/08/13

Type: Interventional study

Primary Sponsor: Xijing Hospital affiliated to Air Force Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322798

Published by HT Digital Content Services with permission from Health Daily Digest....